Proteomics and immunohistochemistry identify loss of nucleophosmin (B23) expression in bladder transitional cell carcinomas

Proteomics and immunohistochemistry identify loss of nucleophosmin (B23) expression in bladder transitional cell carcinomas

מידע ביבליוגרפי
Main Authors:	Ahmad, M, Catto, J, Azzouzi, A, Cross, S, Feeley, K, Eaton, C, Meuth, M, Hamdy, F, Rehman, I
פורמט:	Journal article
שפה:	English
יצא לאור:	2003

פריטים דומים

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations
מאת: Rehman, I, et al.
יצא לאור: (2004)

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.
מאת: Rehman, I, et al.
יצא לאור: (2004)

Tissue microarray immunohistochemistry and cluster analysis confirms the validity of candidate proteins in prostate cancer identified by proteomic analysis of urine
מאת: Rehman, I, et al.
יצא לאור: (2005)

A gene promoter hypermethylation panel to detect transitional cell carcinoma of the bladder
מאת: Yates, DR, et al.
יצא לאור: (2006)

Genetic instability and transitional cell carcinoma of the bladder.
מאת: Catto, J, et al.
יצא לאור: (2004)

Calgizzarin (S100A11) immunostaining pattern is altered in prostate cancer suggesting a role in tumourigenesis
מאת: Rehman, I, et al.
יצא לאור: (2003)

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
מאת: Catto, J, et al.
יצא לאור: (2005)

Promoter hypermethylation identifies progression risk in bladder cancer.
מאת: Yates, DR, et al.
יצא לאור: (2007)

The use of proteomics in urological research
מאת: Rehman, I, et al.
יצא לאור: (2005)

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.
מאת: Yates, DR, et al.
יצא לאור: (2006)

Comparing gene promoter methylation frequencies in urine from patients with bladder cancer with urine from non-cancerous young and elderly control patients
מאת: Yates, DR, et al.
יצא לאור: (2005)

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
מאת: van Oers, J, et al.
יצא לאור: (2009)

Clinically localised prostate cancer is microsatellite stable.
מאת: Azzouzi, A, et al.
יצא לאור: (2007)

Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.
מאת: Catto, J, et al.
יצא לאור: (2003)

Loss of intercellular expression of beta-dystroglycan is a common event in prostate cancer and is significantly associated with loss of differentiation
מאת: Cross, S, et al.
יצא לאור: (2005)

A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis
מאת: Carolien M. Woolthuis, et al.
יצא לאור: (2013-10-01)

Itraq-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression
מאת: Rehman, I, et al.
יצא לאור: (2008)

iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression.
מאת: Glen, A, et al.
יצא לאור: (2008)

Phosphorylation-dependent migration of retinoblastoma protein into the nucleolus triggered by binding to nucleophosmin/B23.
מאת: Takemura, M, et al.
יצא לאור: (2002)

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
מאת: Dhawan, D, et al.
יצא לאור: (2006)

Involvement of nucleophosmin (NPM1/B23) in assembly of infectious HPV16 capsids
מאת: Patricia M. Day, et al.
יצא לאור: (2015-12-01)

Development of a prognostic marker panel in bladder cancer using aberrant promoter methylation
מאת: Catto, J, et al.
יצא לאור: (2007)

Aberrant promoter methylation in pre-malignant and invasive tumours of the urinary bladder
מאת: Yates, D, et al.
יצא לאור: (2005)

Urinary Bladder Xanthoma – Is Immunohistochemistry Necessary?
מאת: M. Raghavendran, et al.
יצא לאור: (2016-09-01)

DNA promoter methylation in urothelial cancer: a feature of the invasive phenotype and a novel therapeutic target
מאת: Catto, J, et al.
יצא לאור: (2006)

Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.
מאת: Catto, J, et al.
יצא לאור: (2003)

Prostate cancer proteomics: The urgent need for clinically validated biomarkers
מאת: Evans, C, et al.
יצא לאור: (2009)

Gli1 appears to be constitutively expressed in the lumenal epithelial cells of the prostate but not in the basal cell layer or the mesenchyme
מאת: Spencer, A, et al.
יצא לאור: (2004)

Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networks.
מאת: Catto, J, et al.
יצא לאור: (2003)

Nucleophosmin 1 expression in acute myeloid leukemia
מאת: Mohammad Davoudi, et al.
יצא לאור: (2015-10-01)

Nucleophosmin 1 expression in acute myeloid leukemia
מאת: Mohammad Davoudi, et al.
יצא לאור: (2015-09-01)

Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
מאת: Rehman, I, et al.
יצא לאור: (2005)

Epigenetic changes in urothelial cancer: A feature of the invasive phenotype and a novel therapeutic target
מאת: Catto, J, et al.
יצא לאור: (2006)

NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
מאת: Markéta Šašinková, et al.
יצא לאור: (2021-01-01)

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.
מאת: Roupret, M, et al.
יצא לאור: (2004)

Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation
מאת: Duangmano Suwit, et al.
יצא לאור: (2012-10-01)

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
מאת: Rouprêt, M, et al.
יצא לאור: (2005)

Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
מאת: Rehman, I, et al.
יצא לאור: (2004)

Targeting chemotherapy to advanced bladder cancer patients most likely to benefit.
מאת: Catto, J, et al.
יצא לאור: (2010)

Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
מאת: Grzegorz Sarek, et al.
יצא לאור: (2010-03-01)